Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIRZEPATIDE Cause Product quality issue? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product quality issue have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.0% of all adverse event reports for TIRZEPATIDE.

10
Reports of Product quality issue with TIRZEPATIDE
0.0%
of all TIRZEPATIDE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product quality issue From TIRZEPATIDE?

Of the 10 reports, 4 (40.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.

Is Product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does TIRZEPATIDE Cause?

Incorrect dose administered (23,301) Injection site pain (10,989) Nausea (10,018) Off label use (7,007) Extra dose administered (6,774) Diarrhoea (5,463) Vomiting (4,635) Injection site haemorrhage (4,389) Accidental underdose (3,897) Injection site erythema (3,844)

What Other Drugs Cause Product quality issue?

ETONOGESTREL (4,651) ALBUTEROL (4,466) TIOTROPIUM (3,821) MOMETASONE FUROATE (3,406) LIDOCAINE (3,126) FLUTICASONE\SALMETEROL (2,986) FORMOTEROL\MOMETASONE FUROATE (2,458) FENTANYL (2,450) NICOTINE (1,987) EXENATIDE (1,839)

Which TIRZEPATIDE Alternatives Have Lower Product quality issue Risk?

TIRZEPATIDE vs TISAGENLECLEUCEL TIRZEPATIDE vs TISLELIZUMAB TIRZEPATIDE vs TISOTUMAB VEDOTIN TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC

Related Pages

TIRZEPATIDE Full Profile All Product quality issue Reports All Drugs Causing Product quality issue TIRZEPATIDE Demographics